Bplus Lab and Cham Yaksa Sign Business Agreement to Strengthen Medical and Pharmaceutical Services

[Asia Economy Reporter Lee Gwan-joo] Bplus Lab, an AI-based medical solution company, announced on the 4th that it has signed a Memorandum of Understanding (MOU) with pharmacy platform company Cham Yaksa to collaborate in the fields of medical and pharmaceutical services.

Through this agreement, both companies plan to pursue multifaceted cooperation, including services, big data, and joint participation in government-supported projects.

Bplus Lab launched the AI-based medical information service platform "Eodi Apa" in 2018, providing AI medical inquiry services. Cham Yaksa is a startup supporting the digital transformation of pharmacies and the expansion of roles for pharmacies and pharmacists based on its platform pharmacies.

Jung Hoon-jae, CEO of Bplus Lab, said, "We are pleased to collaborate with Cham Yaksa, where professional pharmacists work together to promote public health," adding, "Bplus Lab will establish itself as a total healthcare platform encompassing medical and pharmaceutical services by newly offering pharmaceutical services through this cooperation."

Kim Byung-joo, CEO of Cham Yaksa, said, "We expect that the collaboration between two companies with expertise in medical and pharmaceutical fields will create new service models," and added, "Both companies will spare no effort to achieve the common goal of improving public health through cooperation in various fields."

This content was produced with the assistance of AI translation services.